Results 261 to 270 of about 8,631,498 (387)
Targeting RAGE with Nanobodies for Molecular Imaging of Cancers and Alzheimer's Disease
RAGE‐specific nanobodies were isolated via phage display and characterized by ELISA, cell ELISA, and SPR. In vivo imaging in renal carcinoma and Alzheimer's disease mouse models demonstrated that NbF8, the highest‐affinity clone, selectively targeted RAGE‐overexpressing tumors and brain tissues, highlighting its potential as a molecular imaging agent ...
Guangfeng Liang+13 more
wiley +1 more source
Therapeutic Drug Monitoring-Based Population Pharmacokinetics of Amikacin in Patients at a Teaching Hospital. [PDF]
Steffens NA+8 more
europepmc +1 more source
Implementation of a drug therapy monitoring clinic in a primary-care setting [PDF]
Jillmarie K. Yanchick
openalex +1 more source
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi+4 more
wiley +1 more source
Scientific principles for mycophenolic acid therapeutic drug monitoring
Leslie M. Shaw+6 more
openalex +1 more source
Medikamentenbestimmung mit Elektrospray Tandem-Massenspektrometrie. Drug Monitoring by Electrospray Tandem Mass Spectrometry [PDF]
G. Huesgen, Christine Roos, J. Kinkeldei
openalex +1 more source
LIN28B Promotes Cancer Cell Dissemination and Angiogenesis
Children diagnosed with high‐risk neuroblastoma have a 5‐year event‐free survival rate of less than 50% and poor outcomes after recurrence. Deregulation of the LIN28B oncogene can be addressed in these patients. Upregulation of LIN28B is shown to support the metastatic cascade.
Diana Corallo+8 more
wiley +1 more source
Therapeutic drug monitoring in Parkinson's disease. [PDF]
Müller T+5 more
europepmc +1 more source
Pegylated asparaginase (OncasparTM) in children with ALL: drug monitoring in reinduction according to the ALL/NHL‐BFM 95 protocols [PDF]
Hans‐Joachim Müller+12 more
openalex +1 more source